A full service, phase I-IV clinical CRO
e-Clinical excellence
A reliable, cost-competitive solution


OPIS  is celebrating 20 years as full-service clinical CRO.

With 250 employees at nine locations in Europe, we provide premium support for the management of global clinical trials from phase I to IV.  OPIS has extensive experience in a wide range of therapeutic areas and our oncology/immuno-oncology experience amounts to over 400 trials.

Our strength lies in our people and our specialized teams who assist clients from A-Z with medical writing, scientific and statistical consultancy for trial design and skilled teams of operational staff across Europe that ensure high quality project execution.

The OPIS e-Clinical suite is composed of CLINICAL.NET, a modular and extremely user-friendly platform to handle all clinical trial data; a consolidated platform to handle named-patient programmes and an investigator toolkit to facilitate and coordinate patient and clinician participation in the trials. The e-Clinical suite is in-house developed and FDA 21 CRF Part 11 compliant and our data managers, system analysts and web spaecialist collaborate closely to design suitable solutions for a variety of sponsors.

With flexible business models, we shape our offer around customers’ needs and compete very favorably on price.

We are passionate about what we do and we want our name to stand for Excellence.

Motivate creativity and innovate with responsibility

OPIS is celebrating its 20th anniversary as clinical CRO and as we progress through enormous scientific and technological changes in our industry, I would like to reflect on innovation, creativity and responsibility as the fundamental values on which OPIS has built its company culture.

Innovation does not happen on its own, it needs a shared approach, it needs investment, infrastructure, planning and strategy. It means taking risks and moving forward with courage. Most of all, it cannot happen without people, without talented individuals or groups of individuals who flourish in an environment where possibilities for expression are stimulated and valued and where continuous training opportunities favor the generating of new ideas. Innovation is powered by creativity.

Responsibility stems from a sense of belonging where feeling and being part of a team translate into common goals that achieve results. This is OPIS.
In everything we do, we strive to create a working environment where people are valued.

To conclude, a short excerpt from a speech by General Douglass MacArthur to his cadets of 1945:
“Youth is not a period of time.  It is a state of mind, a result of the will, a quality of the imagination, a victory of courage over timidity, of taste for adventure over the love of comfort.  A man doesn’t grow old because he has lived a certain number of years.  A man grows old when he deserts his ideal.  The years may wrinkle his skin, but deserting his ideal wrinkles his soul.  Preoccupations, fears, doubts and despair are the enemies which slowly bow us toward earth and turn us into dust before death.  You will remain young as long as you are open to what is beautiful, good and great; receptive to the messages of other men and women, of nature and of God.  If one day you should become bitter, pessimistic and gnawed by despair, may God have mercy on your old man’s soul.”

 Aldo Poli, CEO 

Our Story

Continuous innovation to support growth

More than 1000 studies managed
Clinical.NET version 3.0 released and validated
New subsidiaries in SE, CH
e-Management of protocol deviations, SAE, study drugs
New subsidiaries in D, FR
European expansion with subsidiaries in UK, B, ES, PL, RO
eClinical Study Portal
ISO 27001 Certification
Proprietary EDC System Validation
ISO 9001 Certification
First clinical research education courses
First audit by a big pharma
First contract with big pharma
Establishment of OPIS

Our Growth

Qualified Team

Aldo Poli

CEO & Co-founder of OPIS

MD degree from the University of Milan.
A reference point in Clinical Research Methodology, Trial design, Statistics and Biometrics.

Over 30 years of experience in the Pharmaceutical Industry and in Clinical Research.

Laura Ambrosoli

Medical Director Co-founder of OPIS

MD degree from School of Medicine and Surgery at the University of Pavia, Specialization in Clinical Pharmacology.

Over 20 years of experience in the Pharmaceutical Industry and in Clinical Research.

Chiara Costantini

Scientific Director, Head of Biometry

MSC in Statistics from the University of Rome.

Joined OPIS in 2015.

More than 20 years of experience in Biostatistics.

Raphaela Schnurbus

Clinical Solutions Director

Degree in Pharmaceutical Sciences from University of Heidelberg and a PhD in Molecular Biology from Ludwig-Maximilians University, Munich.

Joined OPIS in 2015.

More than 15 years in the Drug Development Industry.

Elisabetta Colombo

Director of Administration

Degree in Economics and Commerce from the University “Università Cattolica del Sacro Cuore di Milano”.

Joined OPIS in 2007.

More than 8 years in charge of general accounting and treasury management for OPIS.

Nadia Ambrosoli

Head of Clinical Operations

Graduated from the University of Milan.

Joined OPIS in 2002.

More than 15 years of experience in Clinical Research.

Vittoria Reggiani

Head of Quality

Graduated from the University “Università Cattolica del Sacro Cuore di Milano".

Joined OPIS in 2004.

Over 15 years of experience in Quality management and Clinical Trial management.

Fabio Renna

Head of Information and Communication Technology

Degree in Computer Science from the University of Milan.

Joined OPIS in 2005.

Over 10 years of experience IT architecture and software development, particularly in Clinical Research.

Irene Tagliabue

Head of General Affairs

Degree in Philosophy from the University of Milan.

Joined OPIS in 2006.

More than 10 years in charge of Information security systems and training.

Alessandro Poli

Strategic Advisor

Degree in Economic Science from L.U.de.S in Lugano.

Joined OPIS in 2005.

More than 10 years of executive support in OPIS.